KAN-0441571C

N/A

Report date: 2022/10/23 12:26:53
NME

Base Information

Drug NameKAN-0441571C
Drug Alias NameKAN-0441571KAN0441571C
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInactive tyrosine-protein kinase transmembrane receptor ROR1 antagonistsWnt signalling pathway modulators
TargetsInactive tyrosine-protein kinase transmembrane receptor ROR1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKancera
China Registration ClassN/A

Develop Information

Active CompaniesKancera
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A